Inogen, Inc., a medical technology company, primarily develops, manufactures, and markets portable oxygen concentrators for patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; and Inogen At Home stationary oxygen concentrators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was founded in 2001 and is headquartered in Goleta, California.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [09/23/2019 10:48 PDT] Inogen, Inc. (NASDAQ:INGN), Down By 100.00% ($50.59) From $50.590 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [09/17/2019 21:17 PDT] Market Maker Surveillance Report. INGN, Highest Net Sell Volume and Negative Price Friction For Tuesday, September 17th 2019
• [09/13/2019 10:10 PDT] Inogen, Inc. (NASDAQ:INGN), Up By 100.00% ($47.08) From $47.080 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [09/13/2019 08:00 PDT] INGN Expected to Trade Up After Bullish Patterns Develop